Active Litigation
Breast Mesh Lawsuit Facts
TorHoerman Law is actively accepting claims for the Breast Mesh Lawsuit.
Active Litigation
TorHoerman Law is actively accepting claims for the Breast Mesh Lawsuit.
Breast mesh lawsuit settlement amounts are currently projected between $50,000 to over $500,000 per claimant.
These figures are by no means a guarantee of financial compensation in your breast mesh lawsuit, but are merely estimations based on similar lawsuits involving defective surgical mesh and other medical devices.
TorHoerman Law is investigating the breast mesh lawsuit and helping potential clients understand what types and amounts of compensation they may be entitled to through litigation.

Breast mesh devices, sometimes described as internal bra mesh, are used in certain breast reconstruction and cosmetic procedures to provide added support when natural tissue may not hold shape or implant position on its own.
Comprised of both biologic or synthetic materials, breast mesh implants are placed inside the body to reinforce soft tissue during healing.
Lawsuits are being investigated because some patients report serious complications after receiving these products, including chronic pain, infection, and the need for revision surgery.
In more severe cases, patients have reported wound breakdown, tissue necrosis, implant loss, or other outcomes that require additional, burdensome procedures and long-term treatment.
Potential compensation in a breast mesh claim, if liability and damages are proven, may include medical expenses, lost income, pain-related damages, and compensation for scarring or disfigurement.
The amount a case may be worth depends on the documented injuries, the number and complexity of revision surgeries, whether implant removal was required, the impact on daily life, and the strength of product identification in medical records.
Because breast mesh litigation is still developing and settlement structures are not publicly established, discussions on possible settlement values rely on estimates rather than confirmed payouts.
Lawyers estimate that breast mesh lawsuit settlement amounts may range from $50,000 to over $500,000 per claimant.
The figures presented here are merely estimations based on how other mass tort lawsuits have been structured and the ranges discussed publicly in comparable litigation, and they are not a guarantee of any outcome.
They also do not represent a finding of fault, defect, or liability by any manufacturer, and any compensation determination would depend on the specific facts and evidence of an individual case.
If you or a loved one have suffered complications such as mesh migration, mesh failure, infection, or other injuries, you may be eligible to file a breast mesh lawsuit and seek compensation.
Contact TorHoerman Law today for a free consultation to find out if you qualify for the breast mesh lawsuit.
You can also use the chat feature on this page to find out if you qualify for a breast mesh lawsuit.
Breast mesh lawsuit settlement projections are based on how mass tort claims involving medical devices have historically been evaluated, not on any finalized breast mesh settlement program.
In internal bra and other breast procedures, including implant based breast reconstruction, compensation estimates commonly fall within a broad projected range of $50,000 to over $500,000, depending on the severity of injuries and the supporting evidence.
Claim value is heavily influenced by documented medical complications, including severe pain, infection, mesh migration, and whether a patient required one or more revision surgeries.
Proven past and future medical expenses, such as hospitalization and corrective procedures, directly affect potential compensation.
Economic losses, including lost wages and diminished earning capacity, are also considered when assessing settlement value.
In addition, non-economic damages, such as pain and suffering, permanent disfigurement, scarring, and emotional distress, may increase projected compensation in cases involving serious or lasting medical complications.

Tier 1 is reserved for the most serious internal bra procedures where complications required major medical intervention and left lasting harm.
Cases in this category often involve removal surgery, multiple corrective operations, or extended hospitalization tied to severe post-operative complications.
These claims commonly allege that breast mesh products or mesh materials contributed to a cascade of problems that could not be managed with conservative treatment.
Implant failure, significant wound breakdown, or confirmed skin necrosis often place a case in the highest tier because treatment can be extensive and outcomes can be permanent.
Estimated compensation range: $200,000 to $500,000.
Injuries that may signal a tier 1 case include:
Tier 2 generally applies when internal bra mesh products were used during breast reconstructive surgery and the patient later required at least one corrective operation to address complications that did not resolve with routine care.
These cases often involve medically documented problems such as chronic inflammation, persistent pain, or wound issues that interfere with healing and stability.
Fluid buildup, infection, or surrounding tissue damage may require surgical intervention to protect the implant pocket and prevent escalation.
Estimated compensation range: $100,000 to $200,000, with value influenced by the severity of symptoms, the treatment course, and whether the case shows signs of reconstructive failure.
Injuries that may signal a tier 2 case include:
Tier 3 generally applies when internal bra mesh complications led to meaningful symptoms and documented medical care but did not require major hospitalization or multiple corrective operations.
Patients in this category may still experience severe breast pain, persistent discomfort, or functional limitations that required repeated follow-up visits, imaging, and ongoing treatment.
In breast reconstruction surgery and cosmetic cases, these complications may include fluid collections, inflammation, or early scar-related tightness that improved with conservative care.
Some cases involve minor corrective procedures or limited surgical intervention, but not full implant removal or major reconstructive revision.
Estimated compensation range: $50,000 to $100,000, with the value shaped by medical documentation, duration of symptoms, and the overall impact on daily life.
Injuries that may signal a tier 3 case include:
Breast mesh lawsuit investigations focus on complications reported after surgeons used synthetic mesh, biologic meshes, or other scaffold products to reinforce breast tissue during implant and reconstructive procedures.
In breast augmentation and other augmentation procedures, internal bra breast mesh may be placed as part of an internal bra technique intended to support breast tissue and stabilize the implant pocket during healing.
These products are often cleared for soft tissue repair or reinforcement in general terms, but they have been used in breast surgery settings where patients later reported pain, infection, wound problems, implant malposition, or other complications.
When internal bra complications escalate, treatment can involve revision procedures, prolonged wound care, or mesh removal, sometimes paired with implant exchange or implant removal.
An internal bra lawsuit may allege that patients were not adequately warned about risks associated with placing mesh in delicate breast tissue, especially when the use was outside the product’s breast-specific indications.
Claim reviews also examine whether patients were told that mesh was being implanted, what product was used, and what information was provided about potential complications and revision risk.

Because internal bra breast mesh procedures vary by surgeon technique, material type, and patient anatomy, these investigations tend to be evidence-driven and highly individualized.
The goal of a legal review is to determine whether the medical records support a link between the internal bra technique, the injuries reported, and the damages caused by additional treatment, including mesh removal when required.
Mesh-assisted breast procedures, including internal bra surgery used alongside breast implants, have led to investigations that focus on whether certain manufacturers adequately warned about risks when their products were used in breast applications.
These reviews often involve products marketed for soft-tissue reinforcement or fascial repair that were then adopted in breast surgery settings.
Because these cases are still developing, the list below reflects manufacturers most commonly discussed in current investigations and filings, not a finding of wrongdoing.
The key legal question is usually product identification, what the labeling said at the time, and whether complications in mesh assisted breast procedures were consistent with disclosed risk information.

Breast mesh manufacturers include:
Clinical literature on mesh-assisted breast surgery describes a consistent set of complications, even though reported rates vary by technique, patient population, and the type of mesh used.
A systematic review and meta-analysis of synthetic mesh in implant-based reconstruction reported measurable short-term events such as seroma, infection, reoperation, and explant in the pooled data, confirming these outcomes are not hypothetical.
A separate meta-analysis of biosynthetic mesh in implant-based breast reconstruction likewise reported complications including seroma, hematoma, skin necrosis, infection, and implant loss, which are common endpoints in reconstruction studies.
Peer-reviewed discussions of implant-based reconstruction also identify core complications that affect breast shape and comfort over time, including capsular contracture, malposition, contour deformities, and skin envelope necrosis, which can occur with or without mesh but remain central to post-surgical risk.
In practice, plastic surgeons evaluate whether symptoms reflect expected recovery or whether complications suggest abnormal healing, infection, mechanical instability, or foreign-body reaction involving an internal bra mesh implant.
Evidence also shows outcomes can differ between biologic and synthetic mesh categories, with some analyses explicitly comparing infection and seroma rates across material types.
In lawsuit investigations, patients typically allege that a specific product failed to perform as intended or contributed to injuries suffered, but each case still turns on documentation and individualized medical facts.
Complications and injuries reported in mesh-supported breast procedures include:
Not every complication proves a device defect, and many of these outcomes can occur in breast surgery without mesh.
What matters for a claim review is whether records show an abnormal course tied to the implanted material, including the timing of symptoms and the need for corrective treatment.
Operative reports, revision notes, cultures, and photographs often provide the clearest picture of how the complication developed and whether mesh migration, tissue death, capsular contracture, or other injuries drove additional surgery.
Qualification for a breast mesh lawsuit usually begins with confirming that you underwent breast surgery involving mesh placed to support tissue, stabilize an implant pocket, or reinforce weakened areas.
Many claims involve patients who later developed complications such as infection, wound breakdown, chronic pain, implant malposition, implant loss, or revision surgery.
Evidence identifying the specific manufacturer, brand, and model of the mesh used is essential for claims, and that information is often found in operative reports, implant logs, and device sticker sheets.
To start an internal bra mesh claim, you’ll need to gather evidence including proof you received a breast mesh implant, proof of your injuries, and documentation of the damages you suffered.
Health care providers can be an important source of records, including post-operative notes, culture results, imaging, and revision surgery documentation that show how complications progressed.

Timing matters because the statute of limitations varies by state, typically ranging from one to three years after the injury was discovered, though exact deadlines depend on the jurisdiction and the facts of the case.
Each breast mesh lawsuit is reviewed individually, with settlements and awards reflecting the strength of the legal claim, not a fixed formula.
Current individual lawsuits may eventually be consolidated into a Multidistrict Litigation (MDL), but eligibility for review still depends on your records, your complication history, and the documented impact on your health and livelihood.
Strong evidence is essential in a breast mesh lawsuit because it documents exactly which product was used and how your injuries developed over time.
Medical records also establish the treatment timeline, including when symptoms began, what interventions were required, and whether additional surgery was needed.
Clear documentation helps connect the complications to measurable losses, such as medical bills, time missed from work, and long-term care needs.

Evidence to collect includes:
Damages are the losses a person claims after injuries tied to breast surgery involving mesh, including breast reconstruction, breast lifts, or revision procedures.
Potential damages in breast mesh lawsuits may include medical expenses, lost wages, pain and suffering, and emotional distress.
Lawyers assess damages by reviewing the full medical timeline, the number and complexity of corrective procedures, and the documented financial and personal impact of the injuries, then organizing that proof to advocate for compensation.
Each breast mesh lawsuit is reviewed individually, with settlements and awards reflecting the strength of the legal claim and the severity of harm, not a fixed formula, and successful plaintiffs may recover costs for revision surgeries, medical expenses, pain and suffering, and lost wages.

Damages may include:
Breast mesh complications can lead to prolonged pain, repeat surgeries, implant loss, and permanent changes that affect both health and quality of life.
When these outcomes occur, the medical records and product identification details often determine whether a claim can move forward.
TorHoerman Law reviews breast mesh cases by focusing on surgical documentation, complication timelines, and the full impact of the injuries suffered.

If you believe a breast mesh implant or internal bra procedure contributed to serious complications, TorHoerman Law can evaluate your records and explain whether your case may qualify for legal review.
Contact TorHoerman Law today to request a confidential consultation and learn what next steps may be available.
Not in any publicly established, standardized way.
Breast mesh and internal bra litigation is still developing, and there is no finalized global settlement program or published payout grid that applies across claims.
Any dollar figures discussed online are typically estimates based on other mass tort lawsuits and how settlement tiers are often structured, not verified breast mesh settlement results.
If settlements occur, amounts would be determined case by case based on the strength of the evidence, the severity of complications, the number of corrective surgeries, and the long-term impact on health and livelihood.
Breast mesh and internal bra products have been associated with a range of complications in clinical reports and patient accounts, particularly when healing does not progress as expected or when the body reacts to implanted material.
Reported injuries and complications include:
Many internal bra mesh products entered the market through the FDA’s 510(k) clearance process, which focuses on whether a device is substantially equivalent to an existing product rather than requiring proof of safety and effectiveness for breast-specific applications.
In 2021, the FDA warned that certain acellular dermal matrix (ADM) products, specifically FlexHD and AlloMax, may have significantly higher risks of major complications compared to other products or no ADM use at all.
The FDA has also stated it has not determined the safety and effectiveness of surgical mesh in breast surgery.
In addition, the FDA has described labeling updates for certain mesh products used in breast surgery, with updated warnings and precautions clarifying that these products have not been studied for use in breast reconstructive surgeries.
Internal bra procedures may involve either biologic or synthetic materials used for general soft tissue support.
Biologic options can be made from processed human or animal tissue, including products like the AlloDerm regenerative tissue matrix, which is designed to act as a scaffold for tissue integration.
Synthetic or biosynthetic meshes are manufactured materials intended to provide reinforcement and, depending on the product, may be permanent or absorbable.
Many of these products were originally developed and cleared for broader soft tissue repair applications, which is why patients and lawyers sometimes compare internal bra materials to hernia mesh, since hernia mesh is another category of surgical mesh used to reinforce weakened tissue in a different part of the body.
The key difference is the surgical setting and tissue environment, which can change how mesh behaves and what risks are most likely.

Tor Hoerman has represented injured individuals for more than 30 years, with experience spanning individual personal injury cases and nationwide mass tort litigation. His work includes car accidents, catastrophic injuries, product liability claims, and other serious injury cases. Tor has served in court-appointed leadership roles in national litigation and tried cases involving major corporate defendants.
TorHoerman Law’s legal content is researched and written by our editorial team and attorneys for legal accuracy, clarity, and relevance. We rely on statutes, court records, government publications, medical research, and other authoritative sources when applicable. This page provides general legal information and does not constitute legal advice.
TorHoerman Law reviews its legal content for factual accuracy, current information, and relevant legal context before publication and as material developments occur. This article is provided for general informational purposes and does not constitute legal advice. For guidance about a specific case, contact TorHoerman Law.
You can learn more about this topic by visiting any of our Breast Mesh Lawsuit pages listed below:
A serious injury can change your life.

TorHoerman Law represents people whose lives have been disrupted by serious injuries, unsafe products, and negligence. Our attorneys handle individual personal injury cases as well as national mass tort lawsuits involving major corporations.
Founded in 2009, our legal team brings more than 100 years of combined experience handling serious injury and complex civil litigation.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!

In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.

In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.

In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.

In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.

In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
A serious injury can change your life.